These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 33059979
1. Noninvasive Assessment of Cardiac Output in Advanced Heart Failure and Heart Transplant Candidates Using the Bioreactance Method. Pandhita BAW, Okwose NC, Koshy A, Fernández ÓG, Cruz NB, Eggett C, Velicki L, Popovic D, MacGowan GA, Jakovljevic DG. J Cardiothorac Vasc Anesth; 2021 Jun; 35(6):1776-1781. PubMed ID: 33059979 [Abstract] [Full Text] [Related]
3. Bioreactance Is Not Interchangeable with Thermodilution for Measuring Cardiac Output during Adult Liver Transplantation. Han S, Lee JH, Kim G, Ko JS, Choi SJ, Kwon JH, Heo BY, Gwak MS. PLoS One; 2015 Jun; 10(5):e0127981. PubMed ID: 26017364 [Abstract] [Full Text] [Related]
10. Agreement of Bioreactance Cardiac Output Monitoring With Thermodilution During Hemorrhagic Shock and Resuscitation in Adult Swine. Berlin DA, Peprah-Mensah H, Manoach S, Heerdt PM. Crit Care Med; 2017 Feb; 45(2):e195-e201. PubMed ID: 27749345 [Abstract] [Full Text] [Related]
12. Bioreactance assessment of cardiac output lacks reliability for the follow-up of patients with pulmonary hypertension. Turquier S, Huot L, Lamkhioued M, Subtil F, Traclet J, Ahmad K, Lestelle F, Chauvelot L, Cottin V, Mornex JF. PLoS One; 2024 Feb; 19(5):e0298727. PubMed ID: 38768104 [Abstract] [Full Text] [Related]
13. Peak cardiac power measured noninvasively with a bioreactance technique is a predictor of adverse outcomes in patients with advanced heart failure. Rosenblum H, Helmke S, Williams P, Teruya S, Jones M, Burkhoff D, Mancini D, Maurer MS. Congest Heart Fail; 2010 Feb; 16(6):254-8. PubMed ID: 21091609 [Abstract] [Full Text] [Related]
18. Validity of Hemodynamic Monitoring Using Inert Gas Rebreathing Method in Patients With Chronic Heart Failure and Those Implanted With a Left Ventricular Assist Device. Okwose NC, Bouzas-Cruz N, Fernandez OG, Koshy A, Green T, Woods A, Robinson-Smith N, Tovey S, Mcdiarmid A, Parry G, Schueler S, Macgowan GA, Jakovljevic DG. J Card Fail; 2021 Apr; 27(4):414-418. PubMed ID: 33035686 [Abstract] [Full Text] [Related]
19. NT-proBNP is a weak indicator of cardiac function and haemodynamic response to exercise in chronic heart failure. Parovic M, Okwose NC, Bailey K, Velicki L, Fras Z, Seferovic PM, MacGowan GA, Jakovljevic DG. ESC Heart Fail; 2019 Apr; 6(2):449-454. PubMed ID: 30788904 [Abstract] [Full Text] [Related]
20. Cardiac output measurements using the bioreactance technique in critically ill patients. Fagnoul D, Vincent JL, Backer de D. Crit Care; 2012 Nov 09; 16(6):460. PubMed ID: 23158055 [Abstract] [Full Text] [Related] Page: [Next] [New Search]